7-151013304-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_ModerateBP6_Very_StrongBS2
The NM_000603.5(NOS3):c.3180G>A(p.Glu1060=) variant causes a synonymous change. The variant allele was found at a frequency of 0.00054 in 1,614,124 control chromosomes in the GnomAD database, including 6 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0030 ( 4 hom., cov: 33)
Exomes 𝑓: 0.00028 ( 2 hom. )
Consequence
NOS3
NM_000603.5 synonymous
NM_000603.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 5.88
Genes affected
NOS3 (HGNC:7876): (nitric oxide synthase 3) Nitric oxide is a reactive free radical which acts as a biologic mediator in several processes, including neurotransmission and antimicrobial and antitumoral activities. Nitric oxide is synthesized from L-arginine by nitric oxide synthases. Variations in this gene are associated with susceptibility to coronary spasm. Alternative splicing and the use of alternative promoters results in multiple transcript variants. [provided by RefSeq, Oct 2016]
ATG9B (HGNC:21899): (autophagy related 9B) This gene functions in the regulation of autophagy, a lysosomal degradation pathway. This gene also functions as an antisense transcript in the posttranscriptional regulation of the endothelial nitric oxide synthase 3 gene, which has 3' overlap with this gene on the opposite strand. Mutations in this gene and disruption of the autophagy process have been associated with multiple cancers. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.31).
BP6
Variant 7-151013304-G-A is Benign according to our data. Variant chr7-151013304-G-A is described in ClinVar as [Benign]. Clinvar id is 728798.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High AC in GnomAd4 at 458 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
NOS3 | NM_000603.5 | c.3180G>A | p.Glu1060= | synonymous_variant | 25/27 | ENST00000297494.8 | |
ATG9B | NR_073169.1 | n.2745C>T | non_coding_transcript_exon_variant | 18/18 | |||
ATG9B | NR_133652.1 | n.3482C>T | non_coding_transcript_exon_variant | 17/17 | |||
ATG9B | XR_007060009.1 | n.3525C>T | non_coding_transcript_exon_variant | 15/15 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
NOS3 | ENST00000297494.8 | c.3180G>A | p.Glu1060= | synonymous_variant | 25/27 | 1 | NM_000603.5 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00299 AC: 456AN: 152254Hom.: 4 Cov.: 33
GnomAD3 genomes
AF:
AC:
456
AN:
152254
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000717 AC: 180AN: 251170Hom.: 2 AF XY: 0.000515 AC XY: 70AN XY: 135808
GnomAD3 exomes
AF:
AC:
180
AN:
251170
Hom.:
AF XY:
AC XY:
70
AN XY:
135808
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000283 AC: 414AN: 1461752Hom.: 2 Cov.: 31 AF XY: 0.000238 AC XY: 173AN XY: 727190
GnomAD4 exome
AF:
AC:
414
AN:
1461752
Hom.:
Cov.:
31
AF XY:
AC XY:
173
AN XY:
727190
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00301 AC: 458AN: 152372Hom.: 4 Cov.: 33 AF XY: 0.00299 AC XY: 223AN XY: 74510
GnomAD4 genome
AF:
AC:
458
AN:
152372
Hom.:
Cov.:
33
AF XY:
AC XY:
223
AN XY:
74510
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at